- Home
- MOGU vs SNTI Comparison
MOGU vs SNTI Comparison
Compare MOGU & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- SNTI
- Stock Information
- Founded
- MOGU 2011
- SNTI 2016
- Country
- MOGU China
- SNTI United States
- Employees
- MOGU N/A
- SNTI N/A
- Industry
- MOGU Business Services
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- SNTI Health Care
- Exchange
- MOGU Nasdaq
- SNTI Nasdaq
- Market Cap
- MOGU 16.2M
- SNTI 14.1M
- IPO Year
- MOGU 2018
- SNTI N/A
- Fundamental
- Price
- MOGU $2.11
- SNTI $2.19
- Analyst Decision
- MOGU
- SNTI
- Analyst Count
- MOGU 0
- SNTI 0
- Target Price
- MOGU N/A
- SNTI N/A
- AVG Volume (30 Days)
- MOGU 9.1K
- SNTI 24.1K
- Earning Date
- MOGU 07-09-2024
- SNTI 11-11-2024
- Dividend Yield
- MOGU N/A
- SNTI N/A
- EPS Growth
- MOGU N/A
- SNTI N/A
- EPS
- MOGU N/A
- SNTI N/A
- Revenue
- MOGU $22,206,772.00
- SNTI $338,000.00
- Revenue This Year
- MOGU N/A
- SNTI $254.47
- Revenue Next Year
- MOGU N/A
- SNTI $169.66
- P/E Ratio
- MOGU N/A
- SNTI N/A
- Revenue Growth
- MOGU N/A
- SNTI N/A
- 52 Week Low
- MOGU $1.62
- SNTI $1.52
- 52 Week High
- MOGU $3.58
- SNTI $8.48
- Technical
- Relative Strength Index (RSI)
- MOGU 46.13
- SNTI 39.08
- Support Level
- MOGU $2.04
- SNTI $2.08
- Resistance Level
- MOGU $2.50
- SNTI $2.56
- Average True Range (ATR)
- MOGU 0.26
- SNTI 0.24
- MACD
- MOGU -0.02
- SNTI -0.04
- Stochastic Oscillator
- MOGU 11.21
- SNTI 10.57
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.